Editorial
Focusing on global health and medicine.
Global Health & Medicine. 2019; 1(1):1-2.
Policy Forum
Population aging in Japan: policy transformation, sustainable development goals, universal health coverage, and social determinates of health.
Global Health & Medicine. 2019; 1(1):3-10.
The role of the G20 economies in global health.
Global Health & Medicine. 2019; 1(1):11-15.
Challenges to eliminating the AIDS pandemic in China.
Global Health & Medicine. 2019; 1(1):16-19.
Efficient and practical dissemination of information on viral hepatitis in Japan: an effort by the Hepatitis Information Center, National Center for Global Health and Medicine.
Global Health & Medicine. 2019; 1(1):20-22.
Review
Hepatocellular carcinoma with non-B and non-C hepatitis origin: epidemiology in Japan and surgical outcome.
Global Health & Medicine. 2019; 1(1):23-29.
Diabetic dyslipidemia: evaluation and mechanism.
Global Health & Medicine. 2019; 1(1):30-35.
Original Articles
A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistance.
Global Health & Medicine. 2019; 1(1):36-48.
Non-AIDS-defining malignancies in Japanese hemophiliacs with HIV-1 infection.
Global Health & Medicine. 2019; 1(1):49-54.
Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis.
Global Health & Medicine. 2019; 1(1):55-60.